Viral Vector Services
At Forge, better manufacturing isn’t a benchmark—it’s a mindset. Through innovative technologies and continuous improvement, we deliver end-to-end AAV manufacturing services. Any stage. Any serotype. Built around your journey.
our mission is your impact
Accelerating the Future of Gene Therapy
Our mission is to enable access to life-changing therapies by helping to bring them from concept to reality. That means delivering better, more comprehensive AAV manufacturing services, technologies, and infrastructure so gene therapy developers can deliver more therapies to more patients. Period.


Services
Expert AAV Development
& cGMP Manufacturing
Gene therapy manufacturing takes more than infrastructure. It takes the right team, the right platform, and a partner at every step. Forge offers research-grade production, process development, and cGMP manufacturing alongside in-house plasmid production, molecular development, analytics, quality, fill-finish, stability, and regulatory support—all fully integrated to streamline your path forward.
The FUEL™ Platform
Still developing your process and need a manufacturing solution to streamline your path? Forge’s FUEL™ platform offers a powerful head start—an innovative AAV manufacturing foundation built to help you scale efficiently. With advanced technologies, proven processes, and flexible, product-specific optimizations, FUEL™ can increase productivity while maintaining product quality.
The hearth
Our cGMP Production Facility
To bring gene therapies to patients, you need a facility built for scale, flexibility, global readiness, and unwavering compliance. The Hearth, Forge’s 200,000+ sq. ft. GMP facility, is one of the largest manufacturing sites dedicated to AAV. With 20 GMP suites and bioreactors ranging from 50L to 5,000L, it’s intentionally designed to increase throughput and support efficient production. Built with future growth in mind, The Hearth can expand to meet rising demand. With strict adherence to GMP and safety standards, the facility has been audited by a Qualified Person (QP) and complies with EU GMP—supporting clients with global clinical and
commercial goals.

What Services Are Right For Your Program?
Connect with our experienced AAV manufacturing team for dedicated support throughout your journey.
Frequently Asked Questions
Does Forge Biologics provide AAV CRO services?
Forge Biologics is a CDMO (Contract Development and Manufacturing Organization) and does not provide CRO services. We specialize in AAV manufacturing, offering research-grade production, process development, GMP manufacturing, and integrated support services such as molecular development, analytics, and regulatory consultation. While we don’t provide traditional CRO services—like preclinical or clinical trial management—we work closely with clients to support their manufacturing strategy throughout the development lifecycle and maintain preferred partnerships with CROs that we can connect our clients to as needed.
How quickly can Forge deliver a GMP batch?
Timelines for GMP batch delivery are highly dependent on the specifics of your program, including vector design, process readiness, and scope of work. By partnering with Forge and leveraging our proprietary platform and integrated services—such as in-house analytics and plasmid production—developers may accelerate timelines to GMP manufacturing by up to 30% compared to full process development. Connect with our Client Development team to discuss your program and receive a more detailed scope of work based on your program needs.
The Latest in AAV Manufacturing
-
Affinia Therapeutics and Forge Biologics Announce AAV cGMP Manufacturing Partnership
“We’re proud to support Affinia’s vision of bringing hope to patients affected by cardiomyopathy through their innovative gene therapy.”
-
Forge Biologics Announces the FUEL™ AAV Manufacturing Platform
FUEL™ platform can achieve a 2-6x increase in productivity compared to industry standard, and includes pEMBR 2.0™ Ad helper and modified rep/cap plasmids.
-
Forge Biologics Announces Planned CEO Succession
John Maslowski, Chief Commercial Officer, to succeed Dr. Timothy Miller as President and CEO. “It’s an exciting time at Forge.”